Language
English
Publication Date
9-9-2024
Journal
bioRxiv
DOI
10.1101/2024.09.09.611245
PMID
39314272
PMCID
PMC11419075
PubMedCentral® Posted Date
9-9-2024
PubMedCentral® Full Text Version
Pre-Print
Abstract
Mitochondria are hubs of metabolism and signaling and play an important role in tumorigenesis, therapeutic resistance, and metastasis in many cancer types. Various laboratory models of cancer demonstrate the extraordinary dynamics of mitochondrial structure, but little is known about the role of mitochondrial structure in resistance to anticancer therapy. We previously demonstrated the importance of mitochondrial structure and oxidative phosphorylation in the survival of chemotherapy-refractory triple negative breast cancer (TNBC) cells. As TNBC is a highly aggressive breast cancer subtype with few targeted therapy options, conventional chemotherapies remain the backbone of early TNBC treatment. Unfortunately, approximately 45% of TNBC patients retain substantial residual tumor burden following chemotherapy, associated with abysmal prognoses. Using an orthotopic patient-derived xenograft mouse model of human TNBC, we compared mitochondrial structures between treatment-naïve tumors and residual tumors after conventional chemotherapeutics were administered singly or in combination. We reconstructed 1,750 mitochondria in three dimensions from serial block-face scanning electron micrographs, providing unprecedented insights into the complexity and intra-tumoral heterogeneity of mitochondria in TNBC. Following exposure to carboplatin or docetaxel given individually, residual tumor mitochondria exhibited significant increases in mitochondrial complexity index, area, volume, perimeter, width, and length relative to treatment-naïve tumor mitochondria. In contrast, residual tumors exposed to those chemotherapies given in combination exhibited diminished mitochondrial structure changes. Further, we document extensive intra-tumoral heterogeneity of mitochondrial structure, especially prior to chemotherapeutic exposure. These results highlight the potential for structure-based monitoring of chemotherapeutic responses and reveal potential molecular mechanisms that underlie chemotherapeutic resistance in TNBC.
Published Open-Access
yes
Recommended Citation
Berner, Mariah J; Beasley, Heather K; Vue, Zer; et al., "Three-Dimensional Analysis of Mitochondria in a Patient-Derived Xenograft Model of Triple Negative Breast Cancer Reveals Mitochondrial Network Remodeling Following Chemotherapy Treatments" (2024). Faculty, Staff and Students Publications. 8018.
https://digitalcommons.library.tmc.edu/baylor_docs/8018